Skip to main content

Elevai Labs Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

ELAB$1.61-2.4%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Elevai Labs Inc.
Date: May 15, 2024By:/s/ Jordan R. Plews
Name:Jordan R. Plews
Title:Chief Executive Officer
(Principal Executive Officer)
Date: May 15, 2024By:/s/ Graydon Bensler
Name:Graydon Bensler
Title:Chief Financial Officer
(Principal Accounting and Financial Officer)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.